S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Flexion TherapeuticsDiaMedica TherapeuticsAkebia TherapeuticsOrganogenesisAurinia Pharmaceuticals
SymbolNASDAQ:FLXNN/ANASDAQ:AKBANASDAQ:ORGONASDAQ:AUPH
Price Information
Current Price$15.19N/A$4.14$7.42$4.88
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$25.50N/A$13.50$10.80$16.50
% Upside from Price Target67.87% upsideN/A226.09% upside45.55% upside238.11% upside
Trade Information
Market Cap$561.55 million$565.70 million$506.34 million$706.66 million$467.68 million
Beta1.34-0.021.43N/A1.11
Average Volume619,214131,1511,041,07789,083780,283
Sales & Book Value
Annual Revenue$22.52 millionN/A$207.74 million$193.45 million$460,000.00
Price / Sales25.70N/A2.373.631,000.24
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.91 per shareN/A$5.44 per share$0.52 per share$1.32 per share
Price / Book5.22N/A0.7614.273.70
Profitability
Net Income$-169,660,000.00$-2,220,000.00$-143,590,000.00$-64,830,000.00$-64,120,000.00
EPS($4.49)N/A($2.44)N/A($0.76)
Trailing P/E RatioN/A0.00N/A0.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-368.31%N/A-75.64%N/A-13,231.97%
Return on Equity (ROE)-175.29%N/A-36.92%N/A-50.08%
Return on Assets (ROA)-57.71%N/A-22.10%N/A-40.69%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio3.95%N/A0.06%3.78%N/A
Current Ratio7.80%N/A1.70%1.51%18.98%
Quick Ratio7.33%N/A1.05%1.14%18.98%
Ownership Information
Institutional Ownership Percentage84.62%N/A71.84%1.68%31.12%
Insider Ownership Percentage16.01%N/A2.66%70.40%N/A
Miscellaneous
Employees272N/A32470039
Shares Outstanding38.11 million157.14 million118.86 million94.60 million94.29 million
Next Earnings Date11/6/2019 (Estimated)N/A11/14/2019 (Estimated)11/12/2019 (Confirmed)11/14/2019 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable
 Flexion TherapeuticsDiaMedica TherapeuticsAkebia TherapeuticsOrganogenesisAurinia Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel